Response to NICE Methods of Health Technology Evaluation
NICE recently posted a consultation entitled "The NICE methods of health technology evaluation: the case for change". which detailed its [...]
New Healthcare Venture from Uber Health’s Dan Trigub
Trigub and co-founder Inna Plumb have launched MedArrive as a new care management platform that enables healthcare providers and payers [...]
ICER Analytics™ Accelerates Real-World Application of ICER Reports
The Institute for Clinical and Economic Review (ICER) today formally launched ICER Analytics™, a new cloud-based platform that will revolutionize the [...]
Disruption and Transformation in the COVID Era: 5 Pharma Trends for 2021
The prospective pharmaceutical industry trends first identified by Tribeca Knowledge in late 2019 were all pre-COVID, even though they continue to unfold. [...]
AMCP Nexus 2020: The Specialty Pharmacy Pipeline
The specialty pharmaceutical market is continuing to see increased competition, and in the past 10 years, there has been a [...]
Innovative Payments, Management are Needed for Cell and Gene Therapies
Cell and gene therapies are a transformative approach that provides new therapeutic options for patients with cancer, immune disorders, hemophilia, [...]
MMIT Partners With Leading Patient Access Hubs
Understanding market access is hard. Tracking shifts in coverage and payer policies for pharmaceutical products is even harder. MMIT partners [...]
Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
Little is known about when and what types of real-world evidence (RWE) studies inform pharmacy and therapeutic (P&T) committee decisions. [...]
CMS Announces Drug Payment Reductions with the “Most Favored Nation” Effective January 1, 2021
Centers for Medicare and Medicaid Services (CMS) announced the long-awaited seven year Most Favored Nation (MFN) model as an interim [...]
Reimbursing Innovative and Potentially Curative Gene and Cell Therapies
In this feature, following his participation in a workshop at the International Society for Pharmacoeconomics and Outcomes Research’s 2020 Asia Pacific [...]
Government, Big Pharma, and The People: A Century of Dis-Ease
It can be said that society shapes our values toward drugs and drugs shape society. And while drug prices are [...]
Biden Defers to Experts on COVID-19 Vaccine Prioritization
There will likely be a limited supply of coronavirus vaccine doses available immediately after a vaccine is authorized by the [...]
Digital Approaches in the Era of COVID-19
Recently Mariah Baltezegar, MBA, Executive Director and Head of Peri- and Post-Approval Virtual Trials with Evidera, and Niklas Morton, MSc, [...]
ICER Opens Nominations for New Members of Its Voting Panels
The Institute for Clinical and Economic Review (ICER) is seeking nominations for new members to join its independent evidence review [...]
[Ebook] The Role of Real-world Evidence in FDA Approvals
Global biopharma companies are increasingly using RWE to strengthen regulatory submissions. Aetion’s new eBook is designed to help inform your [...]
Mapping the Landscape of COVID-19 Clinical Trials in the US
An extraordinary amount of global research is underway as the COVID-19 pandemic continues to evolve and spread. As several entities [...]
Elements of Pharmaceutical/Biotech Pricing Short Course
ISPOR announced that it will hold a 4-hour short course entitled ‘Elements of Pharmaceutical/Biotech Pricing Short Course’ on December 9, [...]
Virtual ISPOR 2021 Abstract Submission Deadline Extended
Given the constraints of the current environment, ISPOR has extended the deadline for issue panel and workshop proposals to December [...]
Cytel Acquires Purple Squirrel Economics
Cytel Inc., a leading provider of advanced analytics for the life sciences industry, has announced the acquisition of Purple Squirrel [...]
ICER Analytics™ Launched to Accelerate the Real-World Application of ICER Reports
The Institute for Clinical and Economic Review (ICER) today formally launched ICER Analytics™, a new cloud-based platform that will revolutionize [...]
[Webinar] How Payers, the Life Science Industry, and Others Can Move from Insight to Action
On December 17, 2020, from 10:00 to 11:00 a.m. EST, ICER will host a webinar to demo ICER Analytics™, a [...]
Informed Consent in the Context of COVID-19
Clinical research is world widely speeding in order to identify as soon as possible COVID-19 treatment and vaccine. Clinical trials [...]
ICER Releases Report on Therapies for Anemia in Chronic Kidney Disease
The Institute for Clinical and Economic Review (ICER) today released a Draft Evidence Report assessing the comparative clinical effectiveness and value of [...]
Upcoming ISPOR Webinar Opportunities
ISPOR is offering a number of upcoming webinars that are now available for registration. These webinars are complimentary for both [...]
[Webinar] Use of Real World Evidence in Clinical Development to Enhance Regulatory Submission
More pharmaceutical companies are working to understand how real world evidence (RWE) can strengthen their submission packages and identifying opportunities [...]